Does the FTC have it out for pharma?

And if something happens after we record but before you listen, is that time travel?

May 19, 2023 Check out STAT+

Sponsored By

Does the FTC have it out for pharma? What does it take to make an RSV vaccine? And how do you say "setting cash on fire" in Dutch? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Jared Holz, biotech strategist at Mizuho Securities, joins us to explain why federal regulators are suing to block Amgen's $28 billion merger with Horizon Therapeutics and what it means for the drug industry. We also discuss the latest on Sarepta Therapeutics and its gene therapy for Duchenne muscular dystrophy, a turnaround story in the making at the Belgian drug maker Galapagos, and the effort to secure approval for a maternal RSV vaccine. Listen Now Subscribe to the podcast to never miss an episode iTunes Spotify SoundCloud Stitcher TuneIn YouTube Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser